Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113762.1.4.1146.1629 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1629 |
version | 20220115 |
status | active |
publisher | CSTE Steward |
name | VaccineCVX |
title | Vaccine (CVX) |
date | 2022-01-15T01:02:16-05:00 |
experimental | false |
Usages | (none) |
This value set contains 109 concepts
Code | System | Display |
03 | http://hl7.org/fhir/sid/cvx | measles, mumps and rubella virus vaccine |
08 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
09 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
10 | http://hl7.org/fhir/sid/cvx | poliovirus vaccine, inactivated |
101 | http://hl7.org/fhir/sid/cvx | typhoid Vi capsular polysaccharide vaccine |
102 | http://hl7.org/fhir/sid/cvx | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
104 | http://hl7.org/fhir/sid/cvx | hepatitis A and hepatitis B vaccine |
106 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
110 | http://hl7.org/fhir/sid/cvx | DTaP-hepatitis B and poliovirus vaccine |
113 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
114 | http://hl7.org/fhir/sid/cvx | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |
115 | http://hl7.org/fhir/sid/cvx | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
116 | http://hl7.org/fhir/sid/cvx | rotavirus, live, pentavalent vaccine |
119 | http://hl7.org/fhir/sid/cvx | rotavirus, live, monovalent vaccine |
120 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
121 | http://hl7.org/fhir/sid/cvx | zoster vaccine, live |
130 | http://hl7.org/fhir/sid/cvx | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
133 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate vaccine, 13 valent |
134 | http://hl7.org/fhir/sid/cvx | Japanese Encephalitis vaccine for intramuscular administration |
135 | http://hl7.org/fhir/sid/cvx | influenza, high dose seasonal, preservative-free |
136 | http://hl7.org/fhir/sid/cvx | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |
140 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable, preservative free |
141 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable |
143 | http://hl7.org/fhir/sid/cvx | Adenovirus, type 4 and type 7, live, oral |
144 | http://hl7.org/fhir/sid/cvx | seasonal influenza, intradermal, preservative free |
146 | http://hl7.org/fhir/sid/cvx | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
149 | http://hl7.org/fhir/sid/cvx | influenza, live, intranasal, quadrivalent |
150 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, quadrivalent, preservative free |
155 | http://hl7.org/fhir/sid/cvx | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
158 | http://hl7.org/fhir/sid/cvx | influenza, injectable, quadrivalent, contains preservative |
160 | http://hl7.org/fhir/sid/cvx | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
161 | http://hl7.org/fhir/sid/cvx | Influenza, injectable,quadrivalent, preservative free, pediatric |
162 | http://hl7.org/fhir/sid/cvx | meningococcal B vaccine, fully recombinant |
163 | http://hl7.org/fhir/sid/cvx | meningococcal B vaccine, recombinant, OMV, adjuvanted |
165 | http://hl7.org/fhir/sid/cvx | Human Papillomavirus 9-valent vaccine |
166 | http://hl7.org/fhir/sid/cvx | influenza, intradermal, quadrivalent, preservative free, injectable |
168 | http://hl7.org/fhir/sid/cvx | Seasonal trivalent influenza vaccine, adjuvanted, preservative free |
169 | http://hl7.org/fhir/sid/cvx | Hep A, live attenuated-IM |
170 | http://hl7.org/fhir/sid/cvx | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
171 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |
172 | http://hl7.org/fhir/sid/cvx | cholera, WC-rBS |
173 | http://hl7.org/fhir/sid/cvx | cholera, BivWC |
174 | http://hl7.org/fhir/sid/cvx | cholera, live attenuated |
175 | http://hl7.org/fhir/sid/cvx | Human Rabies vaccine from human diploid cell culture |
176 | http://hl7.org/fhir/sid/cvx | Human rabies vaccine from Chicken fibroblast culture |
177 | http://hl7.org/fhir/sid/cvx | pneumococcal conjugate vaccine, 10 valent |
178 | http://hl7.org/fhir/sid/cvx | Non-US bivalent oral polio vaccine (types 1 and 3) |
179 | http://hl7.org/fhir/sid/cvx | Non-US monovalent oral polio vaccine, unspecified formulation |
183 | http://hl7.org/fhir/sid/cvx | Yellow fever vaccine alternative formulation |
185 | http://hl7.org/fhir/sid/cvx | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |
186 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative |
187 | http://hl7.org/fhir/sid/cvx | zoster vaccine recombinant |
189 | http://hl7.org/fhir/sid/cvx | Hepatitis B vaccine (recombinant), CpG adjuvanted |
19 | http://hl7.org/fhir/sid/cvx | Bacillus Calmette-Guerin vaccine |
190 | http://hl7.org/fhir/sid/cvx | Typhoid conjugate vaccine (non-US) |
191 | http://hl7.org/fhir/sid/cvx | meningococcal A polysaccharide vaccine (non-US) |
192 | http://hl7.org/fhir/sid/cvx | meningococcal AC polysaccharide vaccine (non-US) |
193 | http://hl7.org/fhir/sid/cvx | hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |
195 | http://hl7.org/fhir/sid/cvx | Diphtheria, Tetanus, Poliomyelitis adsorbed |
196 | http://hl7.org/fhir/sid/cvx | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |
197 | http://hl7.org/fhir/sid/cvx | influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free |
198 | http://hl7.org/fhir/sid/cvx | Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |
20 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine |
200 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |
201 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |
202 | http://hl7.org/fhir/sid/cvx | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |
203 | http://hl7.org/fhir/sid/cvx | meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free |
204 | http://hl7.org/fhir/sid/cvx | Ebola Zaire vaccine, live, recombinant, 1mL dose |
205 | http://hl7.org/fhir/sid/cvx | influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free |
206 | http://hl7.org/fhir/sid/cvx | Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection |
207 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
208 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |
21 | http://hl7.org/fhir/sid/cvx | varicella virus vaccine |
210 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |
212 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |
215 | http://hl7.org/fhir/sid/cvx | Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free |
216 | http://hl7.org/fhir/sid/cvx | Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free |
217 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |
218 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |
219 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |
24 | http://hl7.org/fhir/sid/cvx | anthrax vaccine |
25 | http://hl7.org/fhir/sid/cvx | typhoid vaccine, live, oral |
28 | http://hl7.org/fhir/sid/cvx | diphtheria and tetanus toxoids, adsorbed for pediatric use |
33 | http://hl7.org/fhir/sid/cvx | pneumococcal polysaccharide vaccine, 23 valent |
37 | http://hl7.org/fhir/sid/cvx | yellow fever vaccine |
43 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, adult dosage |
44 | http://hl7.org/fhir/sid/cvx | hepatitis B vaccine, dialysis patient dosage |
48 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-T conjugate |
49 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
500 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |
501 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |
502 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |
503 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |
504 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |
505 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |
506 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology |
507 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |
508 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) |
509 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |
510 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |
511 | http://hl7.org/fhir/sid/cvx | SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |
52 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, adult dosage |
56 | http://hl7.org/fhir/sid/cvx | dengue fever vaccine, tetravalent |
62 | http://hl7.org/fhir/sid/cvx | human papilloma virus vaccine, quadrivalent |
75 | http://hl7.org/fhir/sid/cvx | vaccinia (smallpox) vaccine |
77 | http://hl7.org/fhir/sid/cvx | Tick-borne encephalitis vaccine (non-US) |
801 | http://hl7.org/fhir/sid/cvx | AS03 Adjuvant |
83 | http://hl7.org/fhir/sid/cvx | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
94 | http://hl7.org/fhir/sid/cvx | measles, mumps, rubella, and varicella virus vaccine |
Produced 08 Sep 2023